Aurangabad Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-07-2024
- Paid Up Capital ₹ 2.60 M
as on 07-07-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 48.46 M
as on 07-07-2024
- Revenue 44.82%
(FY 2022)
- Profit 48.40%
(FY 2022)
- Ebitda 40.54%
(FY 2022)
- Net Worth 33.08%
(FY 2022)
- Total Assets 3.39%
(FY 2022)
About Aurangabad Institute Of Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.60 M.
The company has closed loans amounting to ₹4.85 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Virendra Jaiswal and Shamal Jugalkishor serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC232148
- Company No.
232148
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2012
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aurangabad Institute Of Medical Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendra Jaiswal  | Director | 14-Jun-2012 | Current |
| Shamal Jugalkishor | Director | 14-Jun-2012 | Current |
Financial Performance and Corporate Structure Insights of Aurangabad Institute Of Medical Sciences.
Aurangabad Institute Of Medical Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.82% increase. The company also saw a substantial improvement in profitability, with a 48.4% increase in profit. The company's net worth Soared by an impressive increase of 33.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurangabad Institute Of Medical Sciences?
In 2020, Aurangabad Institute Of Medical Sciences had a promoter holding of 11.48% and a public holding of 88.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Apr 2016 | ₹1.08 Cr | Satisfied |
Others Creation Date: 07 Apr 2016 | ₹1.66 Cr | Satisfied |
Karur Vysya Bank Creation Date: 09 Jan 2013 | ₹2.10 Cr | Satisfied |
How Many Employees Work at Aurangabad Institute Of Medical Sciences?
Aurangabad Institute Of Medical Sciences has a workforce of 11 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurangabad Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurangabad Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
